Deals



Collagen Solutions Plc Proposes Acquisition of NZ based providers of medical grade collagen


Posted: 21st November 2014 09:18

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that a circular, comprising an Admission Document and including a notice of General Meeting, has today been posted to shareholders.
 
The circular outlines details on:
 
 - The proposed Acquisition of New Zealand based Southern Lights Ventures 2002 Limited (trading as Southern Lights Biomaterials) for a total maximum consideration of NZ$12m (c. £6m) in cash and shares
 - a logical strategic extension and complementary acquisition that provides additional security of supply of high grade collagen
 - Conditional Placing to raise £6m at 7p, representing c. 50.13% of the Enlarged Issued Share Capital at Admission
 - Directors are subscribing for a total of 9,285,714 Placing Shares
 - Appointment of Geoffrey Bennett, co-founder of Southern Lights, as Chief Business Officer
 - Notice of General Meeting to be held at 3 Robroyston Oval, Nova Technology Park, Glasgow G33 1AP on 9am on 9 December 2014.

Related articles



Comments


close

Subscribe to our newsletter

Sign up here and get the latest news and updates delivered directly to your inbox

You can unsubscribe at any time